Kimberly Perez

MedicineBiochemistry, Genetics and Molecular BiologyImmunology and Microbiology

Pilot corpus only

This score is computed over theSindex pilot corpus and does not cover the full scientific literature. Scores are relative to papers we have ingested — papers, authors, and institutions outside the pilot are not represented. Methodology.

Top 100%percentile

0Author DataRank

Indexed papers

0in pilot corpus

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Papers

Driven by 20 papers. Top paper: “The tumor microenvironment drives transcriptional phenotypes and their plasticity in metastatic pancreatic cancer”.

The tumor microenvironment drives transcriptional phenotypes and their plasticity in metastatic pancreatic cancer

bioRxiv (Cold Spring Harbor Laboratory)(2020)10.1101/2020.08.25.256214

N/A

0.986DataRank · unranked

10 citations

Peter Winter, Andrew W. Navia, Hannah L. Williams, Alan DenAdel, Radha L. Kalekar +36 more

Microenvironment drives cell state, plasticity, and drug response in pancreatic cancer

Cell(2021)10.1016/j.cell.2021.11.017

N/A

0.959DataRank · unranked

597 citations

Peter Winter, Andrew W. Navia, Hannah L. Williams, Alan DenAdel, Kristen E. Lowder +42 more

Prediagnostic Inflammation and Pancreatic Cancer Survival

JNCI Journal of the National Cancer Institute(2021)10.1093/jnci/djab040

N/A

0.943DataRank · unranked

24 citations

Vicente Morales‐Oyarvide, Natalia Khalaf, Kimberly Perez, Fred K. Tabung, Gloria Y. F. Ho +13 more

Insulin-Like Growth Factor-1 Receptor Expression and Disease Recurrence and Survival in Patients with Resected Pancreatic Ductal Adenocarcinoma

Cancer Epidemiology Biomarkers & Prevention(2020)10.1158/1055-9965.epi-19-1315

N/A

0.802DataRank · unranked

15 citations

Annacarolina da Silva, Vicente Morales‐Oyarvide, Andressa Dias Costa, Margaret M. Kozak, Richard F. Dunne +23 more

Pembrolizumab alone and pembrolizumab plus chemotherapy in previously treated, extrapulmonary poorly differentiated neuroendocrine carcinomas

British Journal of Cancer(2023)10.1038/s41416-023-02298-8

N/A

0.681DataRank · unranked

11 citations

Jennifer A. Chan, Stephanie J. Wang, Rahul Aggarwal, Susan Calabrese, April DeMore +13 more

Oncogenic Drivers and Therapeutic Vulnerabilities in KRAS Wild-Type Pancreatic Cancer

Clinical Cancer Research(2023)10.1158/1078-0432.ccr-22-3930

N/A

0.581DataRank · unranked

47 citations

Rachel B. Keller, Kevin S. Kapner, Julien Dilly, Srivatsan Raghavan, Chen Yuan +27 more

A Phase I Expansion Cohort Study Evaluating the Safety and Efficacy of the CHK1 Inhibitor LY2880070 with Low-dose Gemcitabine in Patients with Metastatic Pancreatic Adenocarcinoma

Clinical Cancer Research(2023)10.1158/1078-0432.ccr-23-2005

N/A

0.503DataRank · unranked

14 citations

Hanrong Feng, Kalindi Parmar, Junning Wang, Kevin S. Kapner, Bose Kochupurakkal +23 more

The age-dependent association of risk factors with pancreatic cancer

Annals of Oncology(2022)10.1016/j.annonc.2022.03.276

N/A

0DataRank · unranked

77 citations

John Kim, Qiao-Li Wang, Alice A. Lee, Ana Babić, Laufey T. Ámundadóttir +34 more

Neoadjuvant Chemotherapy Is Associated with Altered Immune Cell Infiltration and an Anti-Tumorigenic Microenvironment in Resected Pancreatic Cancer

Clinical Cancer Research(2022)10.1158/1078-0432.ccr-22-1125

N/A

0DataRank · unranked

77 citations

Sara A. Väyrynen, Akhil Chawla, Jinming Zhang, Juha P. Väyrynen, Mai Chan Lau +26 more

Emerging Role of Targeted Therapy in Metastatic Pancreatic Adenocarcinoma

Cancers(2022)10.3390/cancers14246223

N/A

0DataRank · unranked

32 citations

Haley Ellis, Alexander C. Jordan, William A. Freed-Pastor, Kimberly Perez, Douglas A. Rubinson +7 more

Durable clinical benefit from PARP inhibition in a platinum-sensitive, BRCA2-mutated pancreatic cancer patient after earlier progression on placebo treatment on the POLO trial: a case report

Journal of Gastrointestinal Oncology(2021)10.21037/jgo-21-197

N/A

0DataRank · unranked

4 citations

Brian M. Wolpin, Ilana S. Warsofsky, David P. Ryan, Kimberly Perez, Osama E. Rahma +7 more

Pancreatic cancer is associated with medication changes prior to clinical diagnosis

Nature Communications(2023)10.1038/s41467-023-38088-2

N/A

0DataRank · unranked

12 citations

Qiao-Li Wang, Chen Yuan, Alice A. Lee, Ana Babić, Kimmie Ng +10 more

Implementation of systematic genetic counseling (GC) and multigene germline testing (MGT) for pancreatic cancer (PC) patients (pts).

Journal of Clinical Oncology(2020)10.1200/jco.2020.38.4_suppl.678

N/A

0DataRank · unranked

2 citations

Anu Chittenden, Chinedu Ukaegbu, Kimberly Perez, Audrey Madigan, Shraddha Gaonkar +5 more

Phase Ib and Expansion Study of Gemcitabine,Nab-Paclitaxel, and Ficlatuzumab in Patients With Metastatic Pancreatic Cancer

The Oncologist(2023)10.1093/oncolo/oyad002

N/A

0DataRank · unranked

7 citations

Anna M. Chiarella, James M. Cleary, Nora Horick, Colin D. Weekes, Thomas A. Abrams +21 more

Current chemoprevention approaches in Lynch syndrome and Familial adenomatous polyposis: a global clinical practice survey

Frontiers in Oncology(2023)10.3389/fonc.2023.1141810

N/A

0DataRank · unranked

9 citations

Rachel Hodan, Linda Rodgers, Sanjeevani Arora, Francesc Balaguer, José G. Guillem +12 more

Alliance A021804: A prospective, multi-institutional phase II trial evaluating temozolomide versus temozolomide and olaparib for advanced pheochromocytoma and paraganglioma.

Journal of Clinical Oncology(2023)10.1200/jco.2023.41.16_suppl.tps4191

N/A

0DataRank · unranked

5 citations

Kimberly Perez, Susan M. Geyer, Maged Khalil, Aishwarya Vijendran, Andrea Kordaris-Corkill +9 more

Data from Spatially Resolved Single-Cell Assessment of Pancreatic Cancer Expression Subtypes Reveals Co-expressor Phenotypes and Extensive Intratumoral Heterogeneity

(2023)10.1158/0008-5472.c.6514341.v1

N/A

0DataRank · unranked

0 citations

Andressa Dias Costa, Jinming Zhang, Srivatsan Raghavan, Peter Winter, Kevin S. Kapner +34 more

Data from Spatially Resolved Single-Cell Assessment of Pancreatic Cancer Expression Subtypes Reveals Co-expressor Phenotypes and Extensive Intratumoral Heterogeneity

(2023)10.1158/0008-5472.c.6514341

N/A

0DataRank · unranked

0 citations

Andressa Dias Costa, Jinming Zhang, Srivatsan Raghavan, Peter Winter, Kevin S. Kapner +34 more

Spatially Resolved Single-Cell Assessment of Pancreatic Cancer Expression Subtypes Reveals Co-expressor Phenotypes and Extensive Intratumoral Heterogeneity

Cancer Research(2022)10.1158/0008-5472.can-22-3050

N/A

0DataRank · unranked

92 citations

Andressa Dias Costa, Jinming Zhang, Srivatsan Raghavan, Peter Winter, Kevin S. Kapner +34 more

Blockade of IL1β and PD1 with Combination Chemotherapy Reduces Systemic Myeloid Suppression in Metastatic Pancreatic Cancer with Heterogeneous Effects in the Tumor

Cancer Immunology Research(2024)10.1158/2326-6066.cir-23-1073

N/A

0DataRank · unranked

28 citations

Andressa Dias Costa, Emily Kawaler, Victoire Cardot‐Ruffino, Osama E. Rahma, Nina Beri +36 more